Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $458.90 | 16 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $123.89 | 3 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $109.19 | 1 | $0 (2024) |
| GlaxoSmithKline, LLC. | $62.51 | 3 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $39.30 | 2 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $33.82 | 2 | $0 (2019) |
| Penumbra, Inc. | $25.63 | 1 | $0 (2024) |
| Abbott Laboratories | $24.91 | 1 | $0 (2022) |
| Grifols USA, LLC | $14.04 | 1 | $0 (2017) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $13.66 | 1 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $11.95 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $134.82 | 2 | Boehringer Ingelheim Pharmaceuticals, Inc. ($109.19) |
| 2022 | $122.17 | 2 | AstraZeneca Pharmaceuticals LP ($97.26) |
| 2021 | $13.66 | 1 | Otsuka Pharmaceutical Development & Commercialization, Inc. ($13.66) |
| 2020 | $80.22 | 4 | GlaxoSmithKline, LLC. ($40.92) |
| 2019 | $21.61 | 1 | E.R. Squibb & Sons, L.L.C. ($21.61) |
| 2018 | $38.84 | 3 | AstraZeneca Pharmaceuticals LP ($26.63) |
| 2017 | $47.58 | 3 | GlaxoSmithKline, LLC. ($21.59) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/24/2024 | Penumbra, Inc. | Indigo System (Device) | Food and Beverage | Cash or cash equivalent | $25.63 | General |
| Category: Peripheral Intervention | ||||||
| 02/27/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $109.19 | General |
| Category: DIABETES | ||||||
| 10/31/2022 | Abbott Laboratories | PERCLOSE PROGLIDE (Device) | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: Vascular | ||||||
| 01/20/2022 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $97.26 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/11/2021 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Food and Beverage | In-kind items and services | $13.66 | General |
| 11/13/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/29/2020 | GlaxoSmithKline, LLC. | BEXSERO (Biological), PEDIARIX, FLUARIX QUADRIVALENT | Food and Beverage | In-kind items and services | $23.58 | General |
| Category: VACCINES | ||||||
| 10/01/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/19/2020 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: VACCINES | ||||||
| 11/06/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $21.61 | General |
| Category: Cardiovascular | ||||||
| 06/18/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/08/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.21 | General |
| Category: Cardiovascular | ||||||
| 04/27/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.54 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/07/2017 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: RESPIRATORY | ||||||
| 03/24/2017 | Grifols USA, LLC | Prolastin-C (Biological) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Pulmonology | ||||||
| 03/03/2017 | Merck Sharp & Dohme Corporation | ZOSTAVAX (Biological), PNEUMOVAX 23, GARDASIL9 | Food and Beverage | In-kind items and services | $11.95 | General |
| Category: VACCINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 55 | 57 | $36,879 | $8,257 |
| 2022 | 3 | 41 | 41 | $22,454 | $5,771 |
| 2021 | 3 | 52 | 54 | $27,008 | $7,451 |
| 2020 | 5 | 98 | 124 | $38,238 | $9,968 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 55 | 57 | $36,879 | $8,257 | 22.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 11 | 11 | $6,512 | $2,046 | 31.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 13 | 13 | $8,411 | $2,003 | 23.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 17 | 17 | $7,531 | $1,722 | 22.9% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 21 | 22 | $13,024 | $4,135 | 31.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 16 | 16 | $10,352 | $2,441 | 23.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 15 | 16 | $3,632 | $875.63 | 24.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 18 | 34 | $11,118 | $3,028 | 27.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 37 | 47 | $10,669 | $2,663 | 25.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 13 | 13 | $8,411 | $2,203 | 26.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 18 | 18 | $4,104 | $1,097 | 26.7% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 12 | 12 | $3,936 | $976.68 | 24.8% |
About Dr. Emanuel Favela, M.D
Dr. Emanuel Favela, M.D is a Family Medicine healthcare provider based in Maywood, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/21/2010. The National Provider Identifier (NPI) number assigned to this provider is 1952614893.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Emanuel Favela, M.D has received a total of $458.90 in payments from pharmaceutical and medical device companies, with $134.82 received in 2024. These payments were reported across 16 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($458.90).
As a Medicare-enrolled provider, Favela has provided services to 246 Medicare beneficiaries, totaling 276 services with total Medicare billing of $31,447. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine, Infectious Disease
- Location Maywood, IL
- Active Since 07/21/2010
- Last Updated 06/13/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1952614893
Products in Payments
- JARDIANCE (Drug) $109.19
- LOKELMA (Drug) $97.26
- XARELTO (Drug) $39.30
- ELIQUIS (Drug) $33.82
- FARXIGA (Drug) $26.63
- Indigo System (Device) $25.63
- PERCLOSE PROGLIDE (Device) $24.91
- BEXSERO (Biological) $23.58
- ANORO (Drug) $21.59
- SHINGRIX (Biological) $17.34
- Prolastin-C (Biological) $14.04
- ZOSTAVAX (Biological) $11.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Maywood
Dr. Amy Buchanan, M.d, M.D
Family Medicine — Payments: $2,875
Wesam Elramahi, M.d, M.D
Family Medicine — Payments: $1,664
Dr. Irma Perez, M.d, M.D
Family Medicine — Payments: $1,655
Raymond Loza, Md, MD
Family Medicine — Payments: $752.96
Julianna Kacheris, Md, MD
Family Medicine — Payments: $499.94
Maged Basilios, Md Inc, MD INC
Family Medicine — Payments: $305.97